Crane Company (CR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
1 Apr, 2026Executive summary
Annual Meeting scheduled for April 28, 2025, with voting on director elections, auditor ratification, and executive compensation approval.
Strong 2024 financial performance, with significant sales and margin growth in both Aerospace & Electronics and Process Flow Technologies segments.
Strategic actions since 2022 included major acquisitions, divestitures, and the completion of a corporate separation, resulting in a 167% increase in combined equity value since 2020.
Board and management focused on portfolio simplification, growth investments, and operational excellence.
Voting matters and shareholder proposals
Shareholders will vote on electing nine directors for one-year terms, ratifying Deloitte & Touche LLP as independent auditors for 2025, and approving executive compensation in a non-binding advisory vote.
Board recommends voting FOR all proposals.
Board of directors and corporate governance
Board consists of nine members, eight of whom are independent; diversity in gender, ethnicity, and experience is emphasized.
Lead Independent Director role established in 2024 to ensure independent oversight under a combined Chairman/CEO structure.
Annual board and committee self-evaluations, strict overboarding and retirement policies, and majority voting with resignation policy for directors.
Board committees (Audit, Compensation, Nominating/Governance) are fully independent and meet NYSE requirements.
Latest events from Crane Company
- Annual meeting to vote on directors, auditor, and pay, with online and eco-friendly options.CR
Proxy filing1 Apr 2026 - Record results, strategic acquisitions, and strong governance drive value and growth.CR
Proxy filing1 Apr 2026 - Annual meeting to vote on directors, auditor, and executive pay, with board support for all.CR
Proxy filing1 Apr 2026 - Q3 2025 delivered 7.5% sales growth, 27% higher EPS, and a raised full-year outlook.CR
Q3 20253 Feb 2026 - Record 2025 growth and acquisitions set up 10% adjusted EPS growth for 2026.CR
Q4 20252 Feb 2026 - Q2 sales up 14% and adjusted EPS up 18%, with raised full-year guidance and strong segment growth.CR
Q2 20242 Feb 2026 - Q3 2024 saw 13% sales growth, 34% higher EPS, and raised full-year guidance.CR
Q3 202418 Jan 2026 - Q4 adjusted EPS up 58%, sales up 12%, and 2025 guidance raised with a 12% dividend increase.CR
Q4 20249 Jan 2026 - Strong growth, margin expansion, and disciplined M&A set the stage for doubling business size.CR
Gabelli Funds 35th Annual Pump, Valve & Water Symposium7 Jan 2026